Terms: = Pancreatic cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Diagnosis
4 results:
1. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in pancreatic cancer.
Jiang W; Du Y; Zhang W; Zhou W
Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
[TBL] [Abstract] [Full Text] [Related]
2. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer.
Xie Z; Chen X; Li J; Guo Y; Li H; Pan X; Jiang J; Liu H; Wu B
Oncotarget; 2016 May; 7(18):25408-19. PubMed ID: 27028998
[TBL] [Abstract] [Full Text] [Related]
3. Expression and prognostic significance of lncRNA malat1 in pancreatic cancer tissues.
Liu JH; Chen G; Dang YW; Li CJ; Luo DZ
Asian Pac J Cancer Prev; 2014; 15(7):2971-7. PubMed ID: 24815433
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract] [Full Text] [Related]
